Status:
COMPLETED
Comparing the Efficacy of Methylphenidate, Dextroamphetamine and Placebo in Children Diagnosed With ADHD
Lead Sponsor:
Ostfold Hospital Trust
Collaborating Sponsors:
University of Oslo
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
9-14 years
Phase:
PHASE4
Brief Summary
The study compares the efficacy of methylphenidate, dextroamphetamine and placebo on neuropsychological functioning and behavioral symptoms in 36 children diagnosed with ADHD within a double-blind cro...
Eligibility Criteria
Inclusion
- Age from 9.0 to 14.0.
- ADHD diagnosis following assessment at a child \& adolescent outpatient clinic.
- Clarification for stimulant treatment.
Exclusion
- Moderate or severe mental retardation.
- Psychosis.
- Proven brain damage.
- Sensory deficits and/or motor impairments that make the individual in question unsuitable for the relevant tests.
- Epilepsy.
- The child has previously been prescribed stimulant medication or is being treated with such medication.
- The child commutes between parents or there are other factors that substantially reduce the possibility of obtaining reliable observations from parents (The child needs to live in one place through out the whole trial since otherwise might severely influence the child's behaviour and the observations).
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01220440
Start Date
January 1 2006
End Date
December 1 2008
Last Update
October 14 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ostfold Hospital Neuropsychiatric Unit
Fredrikstad, Østfold fylke, Norway, 1605
2
Østfold Hospital Neuropsychiatric Unit
Fredrikstad, Østfold fylke, Norway, 1605